ALPHA BIOLABORATORIES COVID-19 TESTING LIMITED

Executive Summary

ALPHA BIOLABORATORIES COVID-19 TESTING LIMITED exhibits strong liquidity and equity stability, indicating a healthy financial position with no immediate distress signals. However, reliance on related party transactions and a minimal capital base suggest areas for improvement to enhance financial resilience. Focused management of receivables, capital strengthening, and operational expansion are recommended to secure sustainable long-term growth.

View Full Analysis Report →
Company Documents

DateDescription
28/03/2528 March 2025 Total exemption full accounts made up to 2024-03-31

View Document

11/10/2411 October 2024 Confirmation statement made on 2024-09-14 with no updates

View Document

31/03/2431 March 2024 Annual accounts for year ending 31 Mar 2024

View Accounts

29/12/2329 December 2023 Total exemption full accounts made up to 2023-03-31

View Document

12/10/2312 October 2023 Confirmation statement made on 2023-09-14 with no updates

View Document

18/08/2318 August 2023 Confirmation statement made on 2022-09-14 with no updates

View Document

31/03/2331 March 2023 Compulsory strike-off action has been discontinued

View Document

31/03/2331 March 2023 Annual accounts for year ending 31 Mar 2023

View Accounts

31/03/2331 March 2023 Compulsory strike-off action has been discontinued

View Document

30/03/2330 March 2023 Total exemption full accounts made up to 2022-03-31

View Document

07/03/237 March 2023 First Gazette notice for compulsory strike-off

View Document

07/03/237 March 2023 First Gazette notice for compulsory strike-off

View Document

06/04/226 April 2022 Change of details for Mr David Thomas as a person with significant control on 2022-03-31

View Document

06/04/226 April 2022 Director's details changed for Mr David Thomas on 2022-03-31

View Document

31/03/2231 March 2022 Annual accounts for year ending 31 Mar 2022

View Accounts

07/01/227 January 2022 Accounts for a small company made up to 2021-03-31

View Document

07/07/217 July 2021 Confirmation statement made on 2021-07-07 with updates

View Document

07/07/217 July 2021 Director's details changed for Ms Rachel Sarah Davenport on 2021-07-07

View Document

07/07/217 July 2021 Change of details for Ms Rachel Sarah Davenport as a person with significant control on 2021-07-07

View Document

31/08/2031 August 2020 CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION

View Document


More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company